The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: Role of BDNF gene expression

Molecular Brain Research

Volumn 41, Issue 1-2, 1996, Pages 16-26

  Hung, Hui Chuan ^a   Lee, Eminy H Y ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; 1 methyl 4 phenylpyridinium; Brain derived neurotrophic factor; Gene expression; Nucleus accumbens; Reverse transcriptase polymerase chain reaction; Striatum; Substantia nigra; Ventral tegmental area

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE; DOPAMINE RECEPTOR STIMULATING AGENT; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME REPRESSION; GENE EXPRESSION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENETICS; INTOXICATION; LIMBIC SYSTEM; METABOLISM; NERVE TRACT; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALIA;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; ENZYME INDUCTION; GENE EXPRESSION REGULATION; LIMBIC SYSTEM; MALE; MICE; MICE, INBRED BALB C; MPTP POISONING; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0030571034     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00062-9     Document Type: Article

References (43)

1. Alderson R., Alterman A., Barde Y.A., Lindsay R. Brain-derived neurotrophic factor increases survival and differentiation functions of rat septal cholinergic neurons in culture. Neuron. 5:1990;297-306.
2. Altar C., Boylan C., Jackson C., Hershenson S., Miller J., Wiegand S., Lindsay R., Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA. 89:1992;11347-11351.
3. Beck K., Knusel B., Pasinetti G., Michel P., Zawadzka H., Goldstein M., Hefti F. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-phenyl-pyridinium. J. Neurochem. 57:1991;527-532.
4. Beck K., Knusel B., Winslow J., Rosenthal A., Burton L., Nikolics K., Hefti F. Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenylpyridinium. Neurodegeneration. 1:1992;27-36.
5. Beck K. Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons. Prog. Neurobiol. 44:1994;497-516.
6. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18:1995;223-253.
7. Burns R., Chiueh C., Markey S., Ebert M., Jacobowitz D., Kopin I. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
8. Chiba K., Trevor A., Castagnoli N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase, Biochem. Biophys. Res. Commun. 120:1984;574-578.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
10. Ciaranello R., Hoffman H., Shire J., Axelrod J. Genetic regulation of the catecholamine biosynthetic enzymes. II. Inheritance of tyrosine hydroxylase, dopamine-beta-hydroxylase, and phenylethanolamine N-methyltransferase. J. Biol. Chem. 249:1974;4528-4536.
11. Date I., Felten D., Felten S. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res. 519:1990;266-276.
12. DiStefano P., Friedman B., Radziejewski C., Alexander C., Boland P., Schick C., Lindsay R., Wiegand S. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 8:1992;983-993.
13. Dush K., Sikela J., Khan S., Tischfield J., Stambrook P. Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene: presence of a coding region common to animal and bacterial phosphoribosyl-transferases that has a variable intron/exon arrangement. Proc. Natl. Acad. Sci. USA. 82:1985;2731-2735.
14. Elsworth J., Deutch A., Redmond D. Jr., Sladek J. Jr., Roth R. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res. 415:1987;293-299.
15. Gall C., Gold S., Isackson P., Seroogy K. Brain-derived neurotrophic factor and neurotrophin-3 mRNA are expressed in ventral midbrain regions containing dopaminergic neurons. Mol. Cell. Neurosci. 3:1992;56-63.
16. Heikkila R., Hess A., Duvoisin R. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science. 224:1984;1451-1453.
17. Hirsch E., Graybiel A., Agid Y. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 334:1988;345-348.
18. Hofer M., Pagliusi S., Hohn A., Leibrock J., Barde Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9:1990;2459-2464.
19. +) uptake does not explain the differential toxicity of MPTP in the nigrostriatal and mesolimbic dopaminergic pathways. Neurosci. Lett. 196:1995;93-96.
20. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G., Squinto S., Lindsay R. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
21. Hynes M., Poulsen K., Armanini M., Berkemeier L., Phillips H., Rosenthal A. Neurotrophin-. 4 5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures J. Neurosci. Res. 37:1994;144-154.
22. Ichikawa S., Sasaoka T., Nagatsu T. Primary structure of mouse tyrosine hydroxylase deduced from its cDNA. Biochem. Biophys. Res. Commun. 176:1991;1610-1616.
23. Jacobowitz D., Burns R., Chiueh C.C., Irwin J. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey. Psychopharmacol. Bull. 20:1984;416-423.
24. Jansen J.G., Vrieling H., van Zeeland A., Mohn G. The gene encoding hypoxanthine-guanine phosphoribosyltransferase as target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat. Mut. Res. 266:1992;105-116.
25. Javitch J., D'Amato R., Strittmatter S., Snyder S. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA. 82:1985;2173-2177.
26. Javoy-Agid F., Taquet H., Ploska A., Cherif-Zahar C., Ruberg M., Agid Y. Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease. J. Neurochem. 36:1981;2101-2105.
27. Knusel B., Beck K., Winslow J., Rosenthal A., Burton L., Wider H., Nikolics K., Hefti F. Brain-derived neurotrophic factor administration protects forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12:1992;4391-4402.
28. Langston J., Ballard P., Tetrud J., Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
29. Lehmann, A., Atlas Stereotaxique du Cerveau de la Souris, Centre National de la Recherche Scientifique, 1974.
30. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., Barde Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature. 341:1989;149-152.
31. Lowe T., Sharefkin J., Yang S., Sieffenbach C. A computer program for selection of oligonucleotide primers for polymerase chain reactions. Nucl. Acids Res. 18:1990;1757-1761.
32. Moore R., Bloom F. Central catecholamine neuron systems: anatomy and physiology of the DA systems. Annu. Rev. Neurosci. 1:1978;129-169.
33. Peat M., Gibb J. High performance liquid chromatographic determination of indoleamines, dopamine and norepinephrine in rat brain with fluorimetric detection. Anal. Biochem. 128:1983;275-280.
34. Schneider J., Yuwiler A., Markham C. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res. 411:1987;144-150.
35. Segal D., Kuczenski R. Tyrosine hydroxylase activity: regional and subcellular distribution in brain. Brain Res. 68:1974;261-266.
36. Seroogy K., Gall C. Expression of neurotrophins by midbrain dopaminergic neurons. Exp. Neurol. 124:1993;119-128.
37. Shen R.Y., Altar C., Chiodo L. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;8920-8924.
38. Shults C., Kimber T., Altar A. BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. NeuroReport. 6:1995;1109-1112.
39. Sirinathsinghji D., Kupsch A., Mayer E., Zivin M., Pufal D., Oertel W. Cellular localization of tyrosine hydroxylase mRNA and mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Mol. Brain Res. 12:1992;267-274.
40. Spina M., Squinto S., Miller J., Lindsay R., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity involvement of the glutathione system. J. Neurochem. 59:1992;99-106.
41. Venero J., Beck K., Hefti F. 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra. NeuroReport. 12:1994;429-432.
42. Winer, B., Statistical Principles in Experimental Design, McGraw-Hill, New York, 1971.
43. Zafra F., Lindholm D., Castren E., Hartikka J., Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J. Neurosci. 12:1992;4793-4799.